News

ASPIRE meeting

31. January 2023

Working visit at Amsterdam UMC: The partners in the ASPIRE project spent two days at Amsterdam UMC to pave the way for the final year. ASPIRE will ease the access to non-invasiv imaging biomarkers in dementia and help to get ASL into the clinics.

mTRIAL Freesurfer

30. January 2023

The easiest way to use FreeSurfer for brain volume measurements? Upload your FLAIR images to mTRIAL and enjoy the magic.
Interested? Don’t hesitate to contact us.

mTRIAL LST Report

17. January 2023

You want the brain MRIs of your MS patients to be evaluated by the SPM Lesion Segmentation Tool but without installing and adapting any software packages? Or do you need consistent evaluations across multiple centres of a clinical trial? mTRIAL offers Lesion analysis of FLAIR images based on the SPM LST algorithm and produces clear reports. You only need to upload your image data to the mTRIAL platform, pseudonymization is performed on the fly, evaluation and reporting can be done within minutes.
Interested? Don’t hesitate to contact us.

Merry Christmas

20. December 2022

Many thanks to all colleagues, partners and friends for a year full of fruitful discussions, exciting projects and fresh ideas. Enjoy the holidays with your loved ones and have a good start into the new year.

Advancements of ASL

13. December 2022

30 years after the first successful Arterial Spin Labeling (ASL) MR image acquisition to measure cerebral blood flow in rat brain, the early detection of Alzheimer’s using ASL gains enormous importance with the recent publication of the study results for Lecanemab. Now that there is hope for efficient therapies in dementia diseases, it is a good time to review the steps that have been gone since then. Many initiatives aiming at reliable and comparable quantification of brain perfusion measurements are paving the way for broad usage of ASL in clinical studies focusing on Alzheimer‘s and other dementia diseases.

Whitebox

29. November 2022

We are looking forward to the installation of our WHITEBOX at the Universitätsmedizin Mannheim. It will allow for fast and pseudonymized DICOM image transfer from CT scanner to mTRIAL study server. The results of AI based image analysis will be sent directly to the radiologist on duty.

Also looking for easy DICOM upload options? Contact us via info@mediri.com.

International Symposium on Focused Ultrasound

14. November 2022

In honor of todays International Day of Radiology, we want to thank again the attendees of the 8th International Symposium on Focused Ultrasound (23.10.2022 – 27.10.2022) for valuating the contribution of our colleague Jürgen Jenne. The topic covered the first steps towards an automated and generalized definition of target and areas of risk in tcMRgFUS (transcranial therapy with MR-guided focused ultrasound) for tremor therapy. One part of the presented work was to establish a robust method for fiber tracking on brain MR images.

New mTRIAL release

18. October 2022

Our new mTRIAL release will come with a full featured browser based DICOM viewer on board. Designed for clinical trial data management, it supports segmentation, annotation and scoring tasks as defined in the study protocol. The OHIF based tool can be adapted to your personal needs and study requirements.

Curious? Contact us for a free demo via info@mediri.com.

DeepRay project

04. October 2022

We are excited to announce that mediri is working together with the Universitätsmedizin Mannheim on the project “DeepRAY“. The goal of the project is to extend mediri’s mTRIAL platform for AI-based detection of aneurysms and dissections of the aorta on CT images. This will improve the prognosis of patients with life-threatening changes in the abdominal aorta. The investBW project will run for two years and is funded by the Ministerium für Wirtschaft, Arbeit und Tourismus Baden-Württemberg.

Our new COO

02. August 2022

We are delighted to share that we have a new Chief Operations Officer: Julia Müller will from now on take care of mediri’s fortune. She takes over from Prof. Johannes Gregori who will be remaining on board as mediri’s Director of Research.